RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice

FASEB Journal

Volumn 27, Issue 9, 2013, Pages 3619-3631

  Mu, Xiaodong ^a   Usas, Arvydas ^a   Tang, Ying ^a   Lu, Aiping ^a   Wang, Bing ^a   Weiss, Kurt ^a   Huard, Johnny ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Intramyocellular lipid accumulation; Mdx; ROCK; Utrophin

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; DYSTROPHIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UTROPHIN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL FUNCTION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FIBROSIS; HEART MUSCLE; HETEROTOPIC OSSIFICATION; INFLAMMATION; LIPID STORAGE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE NECROSIS; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STEM CELL;

INTRAMYOCELLULAR LIPID ACCUMULATION; MDX; ROCK; UTROPHIN-/-;

ANIMALS; BENZOPYRANS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DYSTROPHIN; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; OSSIFICATION, HETEROTOPIC; RHO GTP-BINDING PROTEINS; UTROPHIN;

EID: 84883442216     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-233460     Document Type: Article

References (72)

1. Cipriano, C. A., Pill, S. G., and Keenan, M. A. (2009) Heterotopic ossification following traumatic brain injury and spinal cord injury. J. Am. Acad. Orthop. Surg. 17, 689-697
2. Marcus, R. L., Addison, O., Kidde, J. P., Dibble, L. E., and Lastayo, P. C. (2010) Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J. Nutr. Health Aging 14, 362-366
3. Miljkovic-Gacic, I., Wang, X., Kammerer, C. M., Gordon, C. L., Bunker, C. H., Kuller, L. H., Patrick, A. L., Wheeler, V. W., Evans, R. W., and Zmuda, J. M. (2008) Fat infiltration in muscle: new evidence for familial clustering and associations with diabetes. Obesity 16, 1854-1860
4. Savage, D. B., Petersen, K. F., and Shulman, G. I. (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87, 507-520
5. Hulver, M. W., and Dohm, G. L. (2004) The molecular mechanism linking muscle fat accumulation to insulin resistance. Proc. Nutr. Soc. 63, 375-380
6. Schulze, P. C. (2009) Myocardial lipid accumulation and lipotoxicity in heart failure. J. Lipid Res. 50, 2137-2138
7. Axelsen, L. N., Lademann, J. B., Petersen, J. S., Holstein-Rathlou, N. H., Ploug, T., Prats, C., Pedersen, H. D., and Kjolbye, A. L. (2010) Cardiac and metabolic changes in longterm high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1560-R1570
8. Ruberg, F. L. (2007) Myocardial lipid accumulation in the diabetic heart. Circulation 116, 1110-1112
9. Sharma, S., Adrogue, J. V., Golfman, L., Uray, I., Lemm, J., Youker, K., Noon, G. P., Frazier, O. H., and Taegtmeyer, H. (2004) Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 18, 1692-1700
10. Momose, M., Iguchi, N., Imamura, K., Usui, H., Ueda, T., Miyamoto, K., and Inaba, S. (2001) Depressed myocardial fatty acid metabolism in patients with muscular dystrophy. Neuromusc. Disord. 11, 464-469
11. Saini-Chohan, H. K., Mitchell, R. W., Vaz, F. M., Zelinski, T., and Hatch, G. M. (2012) Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases. J. Lipid Res. 53, 4-27
12. Ionasescu, V., Monaco, L., Sandra, A., Ionasescu, R., Burmeister, L., Deprosse, C., and Stern, L. Z. (1981) Alterations in lipid incorporation in Duchenne muscular dystrophy. Studies of fresh and cultured muscle. J. Neurol. Sci. 50, 249-251
13. Tahallah, N., Brunelle, A., De La Porte, S., and Laprevote, O. (2008) Lipid mapping in human dystrophic muscle by clustertime- of-flight secondary ion mass spectrometry imaging. J. Lipid Res. 49, 438-454
14. Duan, D. (2006) Challenges and opportunities in dystrophindeficient cardiomyopathy gene therapy. Hum. Mol. Genet. 15(Spec. 2), R253-R261
15. Kikkawa, N., Ohno, T., Nagata, Y., Shiozuka, M., Kogure, T., and Matsuda, R. (2009) Ectopic calcification is caused by elevated levels of serum inorganic phosphate in mdx mice. Cell Struct. Funct. 34, 77-88
16. Nguyen, F., Cherel, Y., Guigand, L., Goubault-Leroux, I., and Wyers, M. (2002) Muscle lesions associated with dystrophin deficiency in neonatal golden retriever puppies. J. Comp. Pathol. 126, 100-108
17. Starkey, J. D., Yamamoto, M., Yamamoto, S., and Goldhamer, D. J. (2011) Skeletal muscle satellite cells are committed to myogenesis and do not spontaneously adopt nonmyogenic fates. J. Histochem. Cytochem. 59, 33-46
18. Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G., and Barnard, P. J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580
19. Grady, R. M., Teng, H., Nichol, M. C., Cunningham, J. C., Wilkinson, R. S., and Sanes, J. R. (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729-738
20. Deconinck, A. E., Rafael, J. A., Skinner, J. A., Brown, S. C., Potter, A. C., Metzinger, L., Watt, D. J., Dickson, J. G., Tinsley, J. M., and Davies, K. E. (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717-727
21. Isaac, C., Wright, A., Usas, A., Li, H., Tang, Y., Mu, X., Greco, N., Dong, Q., Vo, N., Kang, J., Wang, B., and Huard, J. (2013) Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities. J. Orthop. Res. 31, 343-349
22. Muntoni, F., Fisher, I., Morgan, J. E., and Abraham, D. (2002) Steroids in Duchenne muscular dystrophy: from clinical trials to genomic research. Neuromusc. Disord. 12(Suppl. 1), S162-S165
23. Mavrogenis, A. F., Soucacos, P. N., and Papagelopoulos, P. J. (2011) Heterotopic ossification revisited. Orthopedics 34, 177
24. Neal, B., Rodgers, A., Dunn, L., and Fransen, M. (2000) Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst. Rev., CD001160
25. Dahners, L. E., and Mullis, B. H. (2004) Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing. J. Am. Acad. Orthop. Surg. 12, 139-143
26. Vasileiadis, G. I., Sioutis, I. C., Mavrogenis, A. F., Vlasis, K., Babis, G. C., and Papagelopoulos, P. J. (2011) COX-2 inhibitors for the prevention of heterotopic ossification after THA. Orthopedics 34, 467
27. Banovac, K., Williams, J. M., Patrick, L. D., and Levi, A. (2004) Prevention of heterotopic ossification after spinal cord injury with COX-2 selective inhibitor (rofecoxib). Spinal Cord 42, 707-710
28. Joe, A. W., Yi, L., Natarajan, A., Le Grand, F., So, L., Wang, J., Rudnicki, M. A., and Rossi, F. M. (2010) Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153-163
29. Cox, F. M., Reijnierse, M., van Rijswijk, C. S., Wintzen, A. R., Verschuuren, J. J., and Badrising, U. A. (2011) Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis. Rheumatology 50, 1153-1161
30. Mei, M., Zhao, L., Li, Q., Chen, Y., Huang, A., Varghese, Z., Moorhead, J. F., Zhang, S., Powis, S. H., and Ruan, X. Z. (2011) Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice. Lipids Health Dis. 10, 110
31. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91
32. Messina, S., Altavilla, D., Aguennouz, M., Seminara, P., Minutoli, L., Monici, M. C., Bitto, A., Mazzeo, A., Marini, H., Squadrito, F., and Vita, G. (2006) Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am. J. Pathol. 168, 918-926
33. Langen, R. C., Schols, A. M., Kelders, M. C., Wouters, E. F., and Janssen-Heininger, Y. M. (2001) Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor- κB. FASEB J. 15, 1169-1180
34. Lu, A., Proto, J. D., Guo, L., Tang, Y., Lavasani, M., Tilstra, J. S., Niedernhofer, L. J., Wang, B., Guttridge, D. C., Robbins, P. D., and Huard, J. (2012) NF-κB negatively impacts the myogenic potential of muscle-derived stem cells. Mol. Ther. 20, 661-668
35. Monici, M. C., Aguennouz, M., Mazzeo, A., Messina, C., and Vita, G. (2003) Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 60, 993-997
36. Ridley, A. J. (2001) Rho GTPases and cell migration. J. Cell Sci. 114, 2713-2722
37. McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K., and Chen, C. S. (2004) Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell. 6, 483-495
38. Khatiwala, C. B., Kim, P. D., Peyton, S. R., and Putnam, A. J. (2009) ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK. J. Bone. Miner. Res. 24, 886-898
39. Meyers, V. E., Zayzafoon, M., Douglas, J. T., and McDonald, J. M. (2005) RhoA and cytoskeletal disruption mediate reduced osteoblastogenesis and enhanced adipogenesis of human mesenchymal stem cells in modeled microgravity. J. Bone Miner. Res. 20, 1858-1866
40. Wang, Y. K., Yu, X., Cohen, D. M., Wozniak, M. A., Yang, M. T., Gao, L., Eyckmans, J., and Chen, C. S. (2012) Bone morphogenetic protein-2-induced signaling and osteogenesis is regulated by cell shape, RhoA/ROCK, and cytoskeletal tension. Stem Cells Dev. 21, 1176-1186
41. Fromigue, O., Hay, E., Modrowski, D., Bouvet, S., Jacquel, A., Auberger, P., and Marie, P. J. (2006) RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. Cell Death Differ. 13, 1845-1856
42. Hosoyama, T., Ishiguro, N., Yamanouchi, K., and Nishihara, M. (2009) Degenerative muscle fiber accelerates adipogenesis of intramuscular cells via RhoA signaling pathway. Differentiation 77, 350-359
43. Santos, A., Bakker, A. D., de Blieck-Hogervorst, J. M., and Klein-Nulend, J. (2010) WNT5A induces osteogenic differentiation of human adipose stem cells via rho-associated kinase ROCK. Cytotherapy 12, 924-932
44. Goto, K., Chiba, Y., Sakai, H., and Misawa, M. (2009) Tumor necrosis factor-alpha (TNF-alpha) induces upregulation of RhoA via NF-κB activation in cultured human bronchial smooth muscle cells. J. Pharmacol. Sci. 110, 437-444
45. Slice, L. W., Bui, L., Mak, C., and Walsh, J. H. (2000) Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases. Biochem. Biophys. Res. Commun. 276, 406-410
46. Nakayama, Y., Komuro, R., Yamamoto, A., Miyata, Y., Tanaka, M., Matsuda, M., Fukuhara, A., and Shimomura, I. (2009) RhoA induces expression of inflammatory cytokine in adipocytes. Biochem. Biophys. Res. Commun. 379, 288-292
47. Zhou, Y., Huang, X., Hecker, L., Kurundkar, D., Kurundkar, A., Liu, H., Jin, T. H., Desai, L., Bernard, K., and Thannickal, V. J. (2013) Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J. Clin. Invest. 123, 1096-1108
48. Zhou, H., Li, Y. J., Wang, M., Zhang, L. H., Guo, B. Y., Zhao, Z. S., Meng, F. L., Deng, Y. G., and Wang, R. Y. (2011) Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes. Acta Pharmacol. Sin. 32, 999-1008
49. Charrasse, S., Comunale, F., Grumbach, Y., Poulat, F., Blangy, A., and Gauthier-Rouviere, C. (2006) RhoA GTPase regulates M-cadherin activity and myoblast fusion. Mol. Biol. Cell 17, 749-759
50. Castellani, L., Salvati, E., Alema, S., and Falcone, G. (2006) Fine regulation of RhoA and Rock is required for skeletal muscle differentiation. J. Biol. Chem. 281, 15249-15257
51. Beqaj, S., Jakkaraju, S., Mattingly, R. R., Pan, D., and Schuger, L. (2002) High RhoA activity maintains the undifferentiated mesenchymal cell phenotype, whereas RhoA down-regulation by laminin-2 induces smooth muscle myogenesis. J. Cell Biol. 156, 893-903
52. Gharaibeh, B., Lu, A., Tebbets, J., Zheng, B., Feduska, J., Crisan, M., Peault, B., Cummins, J., and Huard, J. (2008) Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat. Protoc. 3, 1501- 1509
53. Thibaud, J. L., Monnet, A., Bertoldi, D., Barthelemy, I., Blot, S., and Carlier, P. G. (2007) Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging. Neuromusc. Disord. 17, 575-584
54. Valentine, B. A., Cooper, B. J., Cummings, J. F., and de Lahunta, A. (1990) Canine X-linked muscular dystrophy: morphologic lesions. J. Neurol. Sci. 97, 1-23
55. Greenberg, A. S., Coleman, R. A., Kraemer, F. B., McManaman, J. L., Obin, M. S., Puri, V., Yan, Q. W., Miyoshi, H., and Mashek, D. G. (2011) The role of lipid droplets in metabolic disease in rodents and humans. J. Clin. Invest. 121, 2102-2110
56. Lounev, V. Y., Ramachandran, R., Wosczyna, M. N., Yamamoto, M., Maidment, A. D., Shore, E. M., Glaser, D. L., Goldhamer, D. J., and Kaplan, F. S. (2009) Identification of progenitor cells that contribute to heterotopic skeletogenesis. J. Bone Joint Surg. Am. 91, 652-663
57. Arking, D. E., Krebsova, A., Macek, M., Sr., Macek, M., Jr., Arking, A., Mian, I. S., Fried, L., Hamosh, A., Dey, S., McIntosh, I., and Dietz, H. C. (2002) Association of human aging with a functional variant of klotho. Proc. Natl. Acad. Sci. U. S. A. 99, 856-861
58. Salisbury, E., Rodenberg, E., Sonnet, C., Hipp, J., Gannon, F. H., Vadakkan, T. J., Dickinson, M. E., Olmsted-Davis, E. A., and Davis, A. R. (2011) Sensory nerve induced inflammation contributes to heterotopic ossification. J. Cell. Biochem. 112, 2748- 2758
59. Straus, D. S., and Glass, C. K. (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol. 28, 551-558
60. Holness, C. L., and Simmons, D. L. (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81, 1607-1613
61. Amin, R. H., Mathews, S. T., Camp, H. S., Ding, L., and Leff, T. (2010) Selective activation of PPARgamma in skeletal muscle induces endogenous production of adiponectin and protects mice from diet-induced insulin resistance. Am. J. Physiol. Endocrinol. Metab. 298, E28-E37
62. Ye, J. M., Doyle, P. J., Iglesias, M. A., Watson, D. G., Cooney, G. J., and Kraegen, E. W. (2001) Peroxisome proliferatoractivated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-γ activation. Diabetes 50, 411-417
63. Finsterer, J., and Stollberger, C. (2003) The heart in human dystrophinopathies. Cardiology 99, 1-19
64. Lehman, J. J., and Kelly, D. P. (2002) Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin. Exp. Pharmacol. Physiol. 29, 339-345
65. Ahmad, N., Bygrave, M., De Zordo, T., Fenster, A., and Lee, T. Y. (2010) Detecting degenerative changes in myotonic murine models of Duchenne muscular dystrophy using high-frequency ultrasound. J. Ultrasound. Med. 29, 367-375
66. Qu-Petersen, Z., Deasy, B., Jankowski, R., Ikezawa, M., Cummins, J., Pruchnic, R., Mytinger, J., Cao, B., Gates, C., Wernig, A., and Huard, J. (2002) Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157, 851-864
67. Smith, P. G., Roy, C., Zhang, Y. N., and Chauduri, S. (2003) Mechanical stress increases RhoA activation in airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 28, 436-442
68. Aghajanian, A., Wittchen, E. S., Campbell, S. L., and Burridge, K. (2009) Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PLoS One 4, e8045
69. Bowerman, M., Beauvais, A., Anderson, C. L., and Kothary, R. (2010) Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum. Mol. Genet. 19, 1468-1478
70. Segain, J. P., Raingeard de la Bletiere, D., Sauzeau, V., Bourreille, A., Hilaret, G., Cario-Toumaniantz, C., Pacaud, P., Galmiche, J. P., and Loirand, G. (2003) Rho kinase blockade prevents inflammation via nuclear factor κB inhibition: evidence in Crohn's disease and experimental colitis. Gastroenterology 124, 1180-1187
71. Ciaraldi, T. P., Cha, B. S., Park, K. S., Carter, L., Mudaliar, S. R., and Henry, R. R. (2002) Free fatty acid metabolism in human skeletal muscle is regulated by PPARγ and RXR agonists. Ann. N. Y. Acad. Sci. 967, 66-70
72. Demer, L. L. (2002) Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int. J. Epidemiol. 31, 737-741